Find link

language:

jump to random article

Find link is a tool written by Edward Betts.

searching for BRCA mutation 12 found (40 total)

alternate case: bRCA mutation

Prophylactic salpingectomy (2,149 words) [view diff] exact match in snippet view article find links to article

fallopian tubes are removed in one operation. However, only 60-70% of BRCA mutation carriers undergo BSO currently, which is related to the generation of
Salpingectomy (637 words) [view diff] case mismatch in snippet view article find links to article
"Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers". Obstetrics & Gynecology. 121 (1): 14–24. doi:10.1097/aog
BACH2 (1,431 words) [view diff] exact match in snippet view article find links to article
"Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease
Age of onset (1,422 words) [view diff] case mismatch in snippet view article find links to article
ISSN 0950-9232. PMID 13679864. Smith, Karen Lisa; Isaacs, Claudine (2011). "BRCA Mutation Testing in Determining Breast Cancer Therapy". The Cancer Journal. 17
Allison Kurian (776 words) [view diff] exact match in snippet view article find links to article
8, 2020. "No higher risk of breast cancer for women who don't have BRCA mutation but have relatives who do". med.stanford.edu. October 31, 2011. Retrieved
Decision analysis (3,167 words) [view diff] exact match in snippet view article find links to article
Angelina Jolie right? Optimizing cancer prevention strategies among BRCA mutation carriers. Decision Analysis, 14, 139–169. Esnaola, N. F., S. B. Cantor
Gynecologic oncology (3,524 words) [view diff] exact match in snippet view article find links to article
PMID 23404857. Neff, Robert T.; Senter, Leigha; Salani, Ritu (August 2017). "BRCA mutation in ovarian cancer: testing, implications and treatment considerations"
Institute of Cancer Research (2,918 words) [view diff] exact match in snippet view article find links to article
(2009). "Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers". New England Journal of Medicine. 361 (2): 123–34. doi:10
High Resolution Melt (2,569 words) [view diff] exact match in snippet view article find links to article
Harris M, et al. (February 2006). "Optimal selection of individuals for BRCA mutation testing: a comparison of available methods". J. Clin. Oncol. 24 (4):
Bevacizumab (6,560 words) [view diff] exact match in snippet view article find links to article
positive status defined by either a deleterious or suspected deleterious BRCA mutation, and/or genomic instability. In the EU, bevacizumab, in combination
Homologous recombination (11,885 words) [view diff] exact match in snippet view article find links to article
(July 2009). "Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers". The New England Journal of Medicine. 361 (2): 123–34. doi:10
Gynecologic cancer disparities in the United States (4,469 words) [view diff] exact match in snippet view article find links to article
Nelson, L.H. Huffman, R. Fu, E.L. Harris. "Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence